Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Aerts

Showing results (241-250 of 361) with videos related to

Pageof 37
Sort By:
JIMD Reports|November 15, 2024
Acid sphingomyelinase deficiency and Gaucher disease in adults: Similarities and differences in two macrophage storage disordersEline C B Eskes, Laura van Dussen, Johannes M F G Aerts, et al.
The Lancet. Oncology|October 20, 2019
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trialGiovanni L Ceresoli, Joachim G Aerts, Rafal Dziadziuszko, et al.
International Immunology|October 11, 2005
Characterization of human phagocyte-derived chitotriosidase, a component of innate immunityMarco van Eijk, Cindy P A A van Roomen, G Herma Renkema, et al.
Hypertension (Dallas, Tex. : 1979)|August 8, 2012
Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosineSaskia M Rombach, Bas van den Bogaard, Eric de Groot, et al.
Atherosclerosis|October 10, 2008
Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular diseaseM de Fost, M Langeveld, R Franssen, et al.
Organic & Biomolecular Chemistry|August 27, 2014
Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitorsKah-Yee Li, Jianbing Jiang, Martin D Witte, et al.
Molecular Genetics and Metabolism|April 22, 2008
Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3Anouk C Vedder, Frank Breunig, Wilma E Donker-Koopman, et al.
Radiology|October 22, 2024
Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON TrialDanrong Zhong, Grigory Sidorenkov, Colin Jacobs, et al.
Journal of Lipid Research|October 14, 2017
In situ visualization of glucocerebrosidase in human skin tissue: zymography versus activity-based probe labelingJeroen van Smeden, Irini M Dijkhoff, Richard W J Helder, et al.
Chemical Communications (Cambridge, England)|March 10, 2015
Development of an acid ceramidase activity-based probeCécile M J Ouairy, Maria J Ferraz, Rolf G Boot, et al.
Pageof 37

Showing results (241-250 of 361) with videos related to

Sort By:
Pageof 37
JIMD Reports|November 15, 2024
Acid sphingomyelinase deficiency and Gaucher disease in adults: Similarities and differences in two macrophage storage disordersEline C B Eskes, Laura van Dussen, Johannes M F G Aerts, et al.
The Lancet. Oncology|October 20, 2019
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trialGiovanni L Ceresoli, Joachim G Aerts, Rafal Dziadziuszko, et al.
International Immunology|October 11, 2005
Characterization of human phagocyte-derived chitotriosidase, a component of innate immunityMarco van Eijk, Cindy P A A van Roomen, G Herma Renkema, et al.
Hypertension (Dallas, Tex. : 1979)|August 8, 2012
Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosineSaskia M Rombach, Bas van den Bogaard, Eric de Groot, et al.
Atherosclerosis|October 10, 2008
Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular diseaseM de Fost, M Langeveld, R Franssen, et al.
Organic & Biomolecular Chemistry|August 27, 2014
Exploring functional cyclophellitol analogues as human retaining beta-glucosidase inhibitorsKah-Yee Li, Jianbing Jiang, Martin D Witte, et al.
Molecular Genetics and Metabolism|April 22, 2008
Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3Anouk C Vedder, Frank Breunig, Wilma E Donker-Koopman, et al.
Radiology|October 22, 2024
Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON TrialDanrong Zhong, Grigory Sidorenkov, Colin Jacobs, et al.
Journal of Lipid Research|October 14, 2017
In situ visualization of glucocerebrosidase in human skin tissue: zymography versus activity-based probe labelingJeroen van Smeden, Irini M Dijkhoff, Richard W J Helder, et al.
Chemical Communications (Cambridge, England)|March 10, 2015
Development of an acid ceramidase activity-based probeCécile M J Ouairy, Maria J Ferraz, Rolf G Boot, et al.
Pageof 37